At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HSCS HeartSciences Inc
Pre-Mkt 08-12 08:48:57 EDT
2.05
-0.02
-0.97%
High2.09
Low2.03
Vol13.10K
Open2.03
D1 Closing2.07
Amplitude2.90%
Mkt Cap7.99M
Tradable Cap6.29M
Total Shares3.90M
T/O26.94K
T/O Rate0.43%
Tradable Shares3.07M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
HeartSciences Gets NASDAQ Notice for Falling Below $2.5 Million Stockholders’ Equity Minimum
Fortitude and Heartsciences (Nasdaq: Hscs) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets
Heart Test Laboratories, Inc., doing business as HeartSciences, is a medical technology company focuses on applying AI-based technology to an ECG to expand and improve an ECG's clinical utility. It is developing AI-ECG solutions to be made available on a hardware agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista also provides conventional ECG information in the same test. The company was incorporated in 2007 and is headquartered in Southlake, Texas.